SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-24-000033
Filing Date
2024-01-03
Accepted
2024-01-03 07:00:16
Documents
3
Period of Report
2024-01-03

Document Format Files

Seq Description Document Type Size
1 6-K zk2430725.htm 6-K 11160
2 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 14177
3 image00002.jpg GRAPHIC 21607
  Complete submission text file 0001178913-24-000033.txt   56422
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

IRS No.: 813676773 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38807 | Film No.: 24504327
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)